IX BIOPHARMA revenue for the last year amounted to 5.91 M SGD, the most of which — 5.16 M SGD — came from its highest performing source at the moment, Specialty Pharmaceutical, the year earlier bringing 13.77 M SGD. The greatest contribution to the revenue figure was made by Australia — last year it brought IX BIOPHARMA 5.12 M SGD, and the year before that — 1.37 M SGD.